EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 3.0

New Drug Approvals in China: An International Comparative Analysis, 2019-2023

Yilong Yan iD, Xiangyu Guo, Ziming Li, Weilin Shi, Min Long, Xiaolin Yue, Fanpu Kong, Zhigang Zhao

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s514132 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yilong Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Drug Approval. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug ApprovalChinaUnited StatesHumansEuropean UnionJapanUnited States Food and Drug Administration

Stichwörter der Autor:innen

first-in-classnew drugspecial approvaltargetstherapeutic areas

Autor:innen und Institutionen

  • Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
  • School of Pharmaceutical Sciences, Capital Medical University, Beijing, People's Republic of China.
  • Data Center, Kangzhou Pharmaceutical Big Data Development and Application Research Institute, Chongqing, People's Republic of China.
  • Data Center, Chongqing Kangzhou Big Data (Group) Co., Ltd, Chongqing, People's Republic of China.
  • Party Committee Office, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
  • School of Medicine, Tsinghua University, Beijing, People's Republic of China.

ORCID-Profile: Yilong Yan

Zitieren

APA

Yan, Y., Guo, X., Li, Z., Shi, W., Long, M., Yue, X., Kong, F., & Zhao, Z. (2025). New Drug Approvals in China: An International Comparative Analysis, 2019-2023. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s514132

Vancouver

Yan Y, Guo X, Li Z, Shi W, Long M, Yue X, et al. New Drug Approvals in China: An International Comparative Analysis, 2019-2023. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s514132

BibTeX
@article{Yan2025,
  author = {Yan, Yilong and Guo, Xiangyu and Li, Ziming and Shi, Weilin and Long, Min and Yue, Xiaolin and Kong, Fanpu and Zhao, Zhigang},
  title = {New Drug Approvals in China: An International Comparative Analysis, 2019-2023},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s514132}
}
Kostenlos starten →